Skip to main content
NIHPA Author Manuscripts logoLink to NIHPA Author Manuscripts
. Author manuscript; available in PMC: 2025 Sep 27.
Published in final edited form as: Brain Stimul. 2025 Mar 5;18(3):659–664. doi: 10.1016/j.brs.2025.02.019

Biophysical effects and neuromodulatory dose of transcranial ultrasonic stimulation

Tulika Nandi a,b, Benjamin R Kop a, Kasra Naftchi-Ardebili c, Charlotte J Stagg d,e, Kim Butts Pauly c,1, Lennart Verhagen a,1
PMCID: PMC12464205  NIHMSID: NIHMS2108020  PMID: 40054576

Abstract

Transcranial ultrasonic stimulation (TUS) has the potential to usher in a new era for human neuroscience by allowing spatially precise and high-resolution non-invasive targeting of both deep and superficial brain regions. Currently, fundamental research on the mechanisms of interaction between ultrasound and neural tissues is progressing in parallel with application-focused research. However, a major hurdle in the wider use of TUS is the selection of optimal parameters to enable safe and effective neuromodulation in humans. In this paper, we will discuss the major factors that determine both the safety and efficacy of TUS. We will discuss the thermal and mechanical biophysical effects of ultrasound, which underlie its biological effects, in the context of their relationships with tunable parameters. Based on this knowledge of biophysical effects, and drawing on concepts from radiotherapy, we propose a framework for conceptualising TUS dose.

Keywords: ultrasound, neuromodulation, biophysical effects, parameters, dose, transcranial ultrasonic stimulation

Introduction

Transcranial ultrasonic stimulation (TUS) is a cutting-edge non-invasive brain stimulation technique with much higher spatial resolution and deep brain stimulation capability compared to electromagnetic techniques. Ultrasound has a variety of biophysical effects on tissues, which in turn drive neurobiological mechanisms that lead to neuromodulation. Although the direct links between biophysical effects and neuromodulation are only partly elucidated, fundamental research focused on filling these gaps is progressing in parallel with application-focused research. The major challenge of how to most appropriately set the large number of tunable TUS parameters, recently defined in the ITRUSST standardised reporting consensus1, remains to be overcome. For fundamental research, manipulating these parameters may allow the development and testing of hypotheses concerning underlying biophysical effects. In application-focused research, establishing a framework for conceptualising ‘dose’ based on adjustable parameters and knowledge of their associations with biophysical effects is essential for designing studies and ensuring reproducibility. Here, we summarise the relationships between tunable TUS parameters and the thermal and mechanical biophysical effects of ultrasound. Subsequently, we propose a framework for conceptualising dose and a definition based on tunable parameters. The relationships between dose, defined in terms of stimulation parameters, and the neuromodulatory effects are mediated by the biophysical effects of ultrasound. Therefore, we believe that a discussion about biophysical effects is critical to the discussion about dose. For instance, if a user wants to manipulate ‘effective dose’ (see section about ‘Conceptualising dose’ for description), a knowledge of the relationships between tunable parameters and biophysical effects is essential. Additionally, we hope that this paper will serve as a summary of the specific aspects of ultrasound physics that are crucial for designing TUS experiments, particularly for an audience whose primary interest and expertise lies in neuromodulation and not in physics. For a full review of empirical papers that have examined the relationships between tunable parameters and neuromodulatory effects, please see Nandi et al2, and for a review of parameters relevant to safety, please see the ITRUSST consensus on biophysical safety3.

Biophysical effects of ultrasound and their relationships with tunable parameters

Ultrasound can interact with tissues, including neurons and glia, through thermal and mechanical mechanisms outlined in Figure 1A. It is likely that ultrasound affects the underlying brain tissue via multiple mechanisms simultaneously. The relative contributions of these mechanisms, however, can be influenced by adjusting the stimulation parameters.

Fig. 1.

Fig. 1.

A. Biophysical effects of ultrasound, including thermal (top left) and mechanical (top right) mechanisms. In the lower panels, the shaded blue area depicts the focal area. B. The bottom-left field depicts ARF displacement, with the transducer on the left and the wave propagation towards the right. ARF strain is denoted denoted between shifted (tip of arrow) and more stationary units. ARF strain increases nonlinearly with both pressure and frequency. C. The bottom-right field conceptually depicts instantaneous particle displacement around the acoustic focus, with the particles in their shifted position at one point in time. Normal strain along the direction of propagation and shear strain with angular distortion are denoted. Particle displacement strain increases with pressure, but remains stable across fundamental frequencies. Both schematic illustrations depicting particle fields and relationships between biophysical effects and frequency/pressure are included to conceptualize the principles and mechanisms discussed in the text. These illustrations are not derived from precise mathematical models or simulations and should be interpreted as qualitative visualizations for explanatory purposes only.

The thermal effects, i.e. heat or energy deposition, are proportional to the integral of ultrasound intensity over time. Heat or energy deposition can be increased by increasing the intensity, the pulse duration, or both. If heat deposition were the only mechanism that affected the temperature, then any two sets of pulses with the same energy deposition would have the same temperature rise. However, heat is continuously removed, via conduction to adjacent areas and blood circulation, albeit at a relatively slow rate on the order of seconds. This means that when a pulse or a pulse train is extended to seconds or longer, the temperature rise is lower than for the same energy deposition over a much smaller time period. Heating is known to have neuromodulatory effects3,4, but for transcranial in vivo applications, in which skull heating is a limiting factor, protocols are specifically designed and chosen to limit heating.

Mechanical effects of TUS can be divided into particle displacement strain, acoustic radiation force (ARF) strain, acoustic streaming, and cavitation. Strain refers to the physical deformation of neurons or parts thereof (e.g., the cell membrane), relative to their original configuration when they experience a pressure or force. Particle displacement strain is caused by the acoustic pressure: tissue is stretched and compressed as the pressure wave passes by. The deformation parallel to the direction of the beam results in normal strain and dominates over shear strain which is caused by unequal deformations at different locations on the axis perpendicular to the beam (Figure 1C). Particle displacement is directly proportional to the applied acoustic pressure and inversely proportional to the fundamental frequency (f0). Therefore, particle displacement is larger at lower frequencies (Figure 1C). However, at lower frequencies, this displacement is also occurring over a larger wavelength. As a result of these opposing relationships, particle displacement strain is constant across frequencies (Figure 1C).

ARF strain, on the other hand, is caused by the acoustic radiation force which is a force along the ultrasound beam in the direction of propagation, exerted on absorbing or reflecting tissues in the US path6. In contrast to particle displacement strain, ARF strain is predominantly shear strain (Figure 1B). When estimated using some simplifying assumptions68, the ARF strain is directly proportional to the intensity (i.e., pressure squared) at the focus (Figure 1B). Using the same logic as above, we estimate strain by normalising the displacement to the wavelength and see that while the ARF itself is proportional to f0, the ARF-induced strain is proportional to f0 squared (Figure 1B).

There are two other key points at play: the temporal and spatial response of these two strains. The particle displacement strain varies temporally with each cycle of the ultrasound pulse. In contrast, while the US is on, the ARF is temporally constant at a given point within the medium8, with the displacement rising exponentially to a maximum over several milliseconds, and decaying exponentially over several milliseconds. Pulsing the US leads to fluctuations in the ARF at the pulse repetition frequency (PRF), a much lower frequency than the fundamental frequency. With respect to the physical location, particle displacement strain is highest at the focus. In contrast, ARF strain is highest where the ARF displacement changes most rapidly, typically in areas adjacent to the focus (Fig B).

In an attenuating medium such as neural tissue, a spatial gradient of ARF is observed as US is absorbed along the beam path. When US passes through a fluid medium, this ARF gradient can cause bulk flow of fluid known as acoustic streaming. The velocity of streaming, and therefore any biological effects caused by it, are highly dependent on the viscosity of the medium, and also the physical boundaries and constraints on the medium.

Cavitation refers to both the pulling of dissolved gas out of sonicated tissues to form gas bubbles, and the oscillation of gas bubbles, including the aforementioned emerging bubbles, existing gas bubbles, or injected microbubbles. Inertial cavitation, a special case of cavitation in which bubbles grow in size and eventually collapse leading to large temperature rises and sudden release of energy, can cause tissue damage and is intentionally avoided during neuromodulation applications. Inertial cavitation is a threshold event i.e., it occurs when a specific threshold, defined by a combination of bubble size, f0 and peak negative pressure, is exceeded. The pressure threshold for inertial cavitation is lower at lower f09.

Please note that our discussion about the relationships between stimulation parameters and biophysical effects is limited to linear regimes i.e., ultrasound waves with equal positive and negative pressure amplitudes. Under some conditions, like multiple transducers opposed to each other, or at an angle, there may be complex interactions, including standing waves. A detailed discussion is beyond the scope of this paper6,10,11, but if standing waves give rise to wave distortion or nonlinear effects, then the relationships and arguments presented in this paper may not hold. The possibility of standing waves is determined by a combination of skull geometry and ultrasound parameters like f0 and pulse duration12, and must be carefully simulated for each experimental scenario. In general, as discussed in detail in the ITRUSST standardised reporting paper1, simulations (or other de-rating procedures) are essential for estimating the true parameters and therefore biophysical effects in situ.

Conceptualising dose

We can build on our current knowledge of ultrasound biophysics and parameters to propose hypotheses about the biophysical effects underlying ultrasonic neuromodulation13, and empirically test their relationships14. The development of integrative theoretical frameworks and comprehensive empirical studies is an area of active research, and no consensus has yet been reached. As noted earlier, in practice, efforts to elucidate the underlying mechanisms will proceed in parallel with efforts to optimise TUS effects for basic science and clinical applications. Therefore, we propose a theoretical framework for conceptualising dose, that is agnostic of the underlying biophysical effect.

Knowledge of dose-response relationships is crucial for designing research protocols and for clinical applications. Initial attempts to define acoustic dose have drawn on ideas from radiotherapy15, and in line with radiotherapy, a distinction must be made between exposure and dose. Shaw et al.15 describe exposure as the ‘energy flux or the acoustic pressure of an ultrasonic wave incident on the region of interest’. Exposure is determined by the source transducer and acoustic properties of the medium. The derated or simulated acoustic pressures/intensities reported in neuromodulation studies are, in essence, measures of exposure. In other words, this is the pressure that the target region of interest is exposed to, after taking into account any attenuation caused by tissues between the transducer and target.

Dose, on the other hand, depends on the interaction of the incident ultrasound wave with the neural tissues of interest. In radiotherapy, there are further distinctions between the absorbed, equivalent, and effective dose. Absorbed dose refers to the amount of energy deposited in the tissues. When a region of interest is exposed to ultrasound, only a fraction of the energy carried by the ultrasound wave is absorbed within this region, while the rest passes through. Absorbed dose is a useful quantity when determining the thermal effects of ultrasound since heating is proportional to the absorbed fraction. An analogue for mechanical effects is that ARF at a given spatial location relates to the energy absorbed at that location.

In radiotherapy, equivalent dose additionally accounts for the differing effects of different types of radiation. The analogue for ultrasound stimulation applications is the biophysical effect underlying any neuromodulatory effects. For instance, for thermal effects, equivalent dose, and therefore temperature rise, simply increases with increasing intensity. However, if neuromodulation is primarily driven by mechanical effects, given a constant exposure, the equivalent dose would increase with increasing f0 for ARF strain-dependent effects, but be independent of f0 for particle displacement strain-dependent effects.

Effective dose accounts for the differing sensitivities of various target tissues, in this case, the target neurons or brain region, to the same equivalent dose. In the context of thermal effects, the same temperature rise may have different effects in different brain regions. If mechanical effects are mediated by mechanosensitive ion channels, given the same equivalent dose, the effective dose required to elicit similar responses would differ based on the density of such channels in different target regions16. Another example is the variation in stiffness between brain regions17, and due to ageing and pathology1820. Given the same acoustic pressures and ARFs, the strain and consequent biological effects will vary based on the stiffness of the target tissue. Importantly, the concept of ‘effective dose’ should consider the multiple levels of organisation at which ultrasound exerts effects, from biophysics to cellular biomechanisms, to circuit-level neurophysiology, to the human brain and behaviour, and to clinical outcomes, while also accounting for the state of the system when stimulation is applied (for review, please see2). Ultrasound can have different, even opposing, effects on individual levels. For example, a specific ultrasound protocol and dose might selectively facilitate inhibitory neurons, leading to neural excitation but circuit-level inhibition21. Effective dose is not a property of the stimulation parameters alone but of the interaction with neural systems. Indeed, investigations of effective dose will require an integrative approach bridging across all levels, from biophysics to cellular biomechanisms, to circuit-level neurophysiology, to the human brain and behaviour, and to clinical outcomes.

Finally, when ultrasound leads to neuroplastic effects, the effect of ultrasound will depend on the history of exposure or dosing, and therefore, it is important to record cumulative dose. For TUS, we therefore propose a framework that includes absorbed, equivalent, effective, and cumulative dose (Figure 2). While this framework is useful to clarify and further our understanding of ultrasonic neuromodulation, there is currently, limited consensus about the biophysical mechanisms and neuronal or regional sensitivities of ultrasound. As our knowledge of TUS expands, we expect the definitions of dose to evolve. For instance, equivalent dose might be weighted by fundamental frequency while effective dose might be weighted by intrinsic mechanosensitive ion channel density.

Fig. 2.

Fig. 2.

Theoretical framework for conceptualising transcranial ultrasonic stimulation dose. Absorbed dose depends on the interaction of the incident ultrasound wave with the neural tissues of interest. Equivalent dose additionally accounts for the biophysical effects of ultrasound which drive neuromodulation. Effective dose accounts for the differing sensitivities of target neurons or brain region.

We propose the integral of amplitude over time as a preliminary definition for dose. Since intensity is proportional to the pressure squared, any relationship between neuromodulatory effects and intensity, would also hold for pressure squared. Until we have reached an informed consensus on the mechanisms underlying ultrasonic neuromodulation, we cannot distinguish between exposure and dose and thus we can use them interchangeably as ‘exposed dose’. All other parameters being constant, increasing pressure increases heating, ARF, particle displacement, and the probability of cavitation. Therefore, the intensity over time is likely to be an important factor in dose, irrespective of the underlying biophysical effects. Time is included in the definition because prolonged exposure could either lead to cumulative effects on a single neuron, for instance by allowing greater time for ion movement and changes in membrane potential22, or increase the probability of recruiting additional neurons.

The following equation can be used to estimate dose i.e., integral of intensity over time:

Dose=0tIdt,where

‘I’ is instantaneous intensity

‘t’ is the time over which dose is calculated. This could be the pulse, pulse train or pulse train repeat duration, but may also be calculated over longer time periods (like sessions across multiple days) based on the experiment or application.

If the Isppa accounts for the ramping at the pulse level and there is no ramping at other temporal levels, this reduces to:

Dose=Isppa*PD*1/PRI*PTD[*1/PTRI*PTRD],where

‘Isppa’ is the spatial peak pulse average intensity

PD is the pulse duration

PRI is the pulse repetition interval

PTRI is the pulse train repetition interval

PTRD is the pulse train repetition duration

When Isppa is expressed in W/cm2 and durations are expressed in s, the estimated dose is in J/cm2. Again, longer time scales can be added to the equation as required. Table 1 shows an estimation of dose using Murphy et al.23 as an example.

Table 1:

Example parameters and estimated exposed dose from Murphy et al. 202423.

Duration (s) Ramp duration Ramp shape Pulse repetition interval / Frequency Isppa (W/cm2) (exposed) Dose Pulse Train (J/cm2) Observed dose effect
Murphy et al., 2024
Pulse 0.08 0 rectangular 0.4s/2.5Hz 0.3 / 1.2 / 2.3 / 3.7 / 5.4 / 7.4 0.3 / 1.2 / 2.3 / 3.7 / 5.4 / 7.4 In thalamic excitatory neurons, the initial excitatory response magnitude increases with increasing dose up to 5.4 J/cm2 and plateaus after that. The subsequent depression is observed only at 3.7 J/cm2, but not at higher or lower doses.
Pulse Train 5 0 rectangular

Existing empirical data support our proposed definition. However, several aspects of dose have yet to be comprehensively explored. While both in vitro and in vivo data suggest a scaling of response with intensity and duration, the exact nature of the dose-response relationship is currently unclear. Specifically, dose-response relationships may not always be linear, not even monotonic24. Further, the identification of thresholds and ceilings is crucial to avoid underdosing and minimise side effects. Lastly, it is important to consider the potential impact of dose-rate, over and above total dose25. Note, for example, that the same integral of intensity over time can be achieved by applying either a low-pressure wave for a prolonged duration or a high-pressure wave for a short time-period. However, for thermal effects, greater temperature increases are achieved when energy is delivered over a short time period (a high dose-rate), compared to a low dose-rate where more time is available for the heat to dissipate. In terms of mechanical effects, the dose-rate might interact with the viscoelastic properties of neurons. Indeed, the impact of dose-rate should be a key focus area for future empirical research. Given the complexities of the above factors, we advise against conflating dose with pulsing regimes, such as intending to change dose, by changing the pulse duty cycle. For example, given a constant amplitude, a change from 20% to 40% duty cycle could be considered a doubling of dose, while a change from 20% to 100% duty cycle would fundamentally alter the pulsing regime to a continuous wave which may even be less effective2,24. Accounting for these considerations, our proposed definition of dose is a pragmatic and neutral starting point, while our understanding of ultrasonic neuromodulatory mechanisms continues to improve.

Conclusions

In this paper, we summarise how the bioeffects of ultrasound can be tuned by adjusting the parameters of the application. We provide a theoretical framework for conceptualising dose and propose a preliminary definition for US dose that is agnostic to the underlying biophysical effect.

Funding acknowledgements:

KN is supported by a grant from the National Institutes of Health (NIH R01 EB032743). CJS holds a Senior Research Fellowship, funded by the Wellcome Trust (224430/Z/21/Z). KBP is supported by grants from the National Institutes of Health (NIH R01 MH131684, NIH R01NS112152, NIH R01 EB032743). LV is supported by a VIDI fellowship (18919) funded by the Dutch Research Council (NWO), by an Open Call HHT (HiTMaT-38H3) funded by Holland High Tech, and is a co-applicant on an EIC Pathfinder project (CITRUS, 101071008) funded by the European Innovation Council (EIC) and on an ERC Advanced project (MediCoDe) funded by the European Research Council (ERC).

Footnotes

CRediT author statement:

TN: conceptualization, writing - original draft, writing - review & editing, visualization, project administration; KBP: conceptualization, writing - original draft, writing - review & editing, visualization; BRK: writing - review & editing, visualization; KN: writing - review & editing, visualization; CJS: conceptualization, writing - review & editing; LV: conceptualization, writing - original draft, writing - review & editing, supervision, funding acquisition.

Declarations of interest:

KBP has no competing interests related to the reported work. Unrelated to the reported work, KBP has a relationship with MR Instruments, having received equipment on loan, and with Attune Neurosciences as a consultant. LV has no competing interests related to the reported work. Unrelated to the reported work, LV has a relationship with Brainbox Initiative as a member of the scientific committee, with Nudge LLC, having received consulting fees, with Sonic Concepts Ltd, having received equipment on loan, and with Image Guided Therapy, having received equipment on loan.

References:

  • 1.Martin E et al. ITRUSST Consensus on Standardised Reporting for Transcranial Ultrasound Stimulation. arXiv preprint arXiv:2402.10027 (2024). [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 2.Nandi T, Pauly KB, Kop BR, Stagg CJ & Verhagen L The relationship between parameters and effects in transcranial ultrasonic stimulation. (2024). [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 3.Darrow DP, O’Brien P, Richner TJ, Netoff TI & Ebbini ES Reversible neuroinhibition by focused ultrasound is mediated by a thermal mechanism. Brain stimulation 12, 1439–1447 (2019). [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 4.Shapiro MG, Homma K, Villarreal S, Richter C-P & Bezanilla F Infrared light excites cells by changing their electrical capacitance. Nature communications 3, 736 (2012). [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 5.Duck FA, Baker AC & Starritt HC Ultrasound in Medicine. (CRC Press, 2020). [Google Scholar]
  • 6.Naftchi-Ardebili K et al. Focal Volume, Acoustic Radiation Force, and Strain in Two-Transducer Regimes. arXiv preprint arXiv:2404.13552 (2024). [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 7.Kim YH et al. Acoustic radiation force for analyzing the mechanical stress in ultrasound neuromodulation. Physics in Medicine & Biology 68, 135008 (2023). [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 8.Prieto ML, Oralkan Ö, Khuri-Yakub BT & Maduke MC Dynamic Response of Model Lipid Membranes to Ultrasonic Radiation Force. PLoS ONE 8, e77115 (2013). [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 9.Apfel RE & Holland CK Gauging the likelihood of cavitation from short-pulse, low-duty cycle diagnostic ultrasound. Ultrasound in medicine & biology 17, 179–185 (1991). [DOI] [PubMed] [Google Scholar]
  • 10.Kim YH et al. High-spatial-resolution transcranial focused ultrasound neuromodulation using frequency-modulated pattern interference radiation force. Ultrasonics 140, 107298 (2024). [DOI] [PubMed] [Google Scholar]
  • 11.Kim YH et al. Patterned interference radiation force for transcranial neuromodulation. Ultrasound in Medicine & Biology 48, 497–511 (2022). [DOI] [PubMed] [Google Scholar]
  • 12.Darmani G et al. Non-invasive transcranial ultrasound stimulation for neuromodulation. Clinical Neurophysiology 135, 51–73 (2022). [DOI] [PubMed] [Google Scholar]
  • 13.Riis T & Kubanek J Effective Ultrasonic Stimulation in Human Peripheral Nervous System. IEEE Trans. Biomed. Eng 69, 15–22 (2022). [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 14.King RL, Brown JR, Newsome WT & Pauly KB Effective parameters for ultrasound-induced in vivo neurostimulation. Ultrasound in medicine & biology 39, 312–331 (2013). [DOI] [PubMed] [Google Scholar]
  • 15.Shaw A, Ter Haar G, Haller J & Wilkens V Towards a dosimetric framework for therapeutic ultrasound. International Journal of Hyperthermia 31, 182–192 (2015). [DOI] [PubMed] [Google Scholar]
  • 16.Zhu J et al. The mechanosensitive ion channel Piezo1 contributes to ultrasound neuromodulation. Proc. Natl. Acad. Sci. U.S.A 120, e2300291120 (2023). [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 17.Burman Ingeberg M, Van Houten E & Zwanenburg JJM Estimating the viscoelastic properties of the human brain at 7 T MRI using intrinsic MRE and nonlinear inversion. Human Brain Mapping hbm.26524 (2023) doi: 10.1002/hbm.26524. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 18.Sack I et al. The impact of aging and gender on brain viscoelasticity. NeuroImage 46, 652–657 (2009). [DOI] [PubMed] [Google Scholar]
  • 19.Murphy MC et al. Regional brain stiffness changes across the Alzheimer’s disease spectrum. NeuroImage: Clinical 10, 283–290 (2016). [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 20.Jerusalem A et al. Electrophysiological-mechanical coupling in the neuronal membrane and its role in ultrasound neuromodulation and general anaesthesia. Acta Biomaterialia 97, 116–140 (2019). [DOI] [PubMed] [Google Scholar]
  • 21.Murphy KR et al. A tool for monitoring cell type–specific focused ultrasound neuromodulation and control of chronic epilepsy. Proc. Natl. Acad. Sci. U.S.A 119, e2206828119 (2022). [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 22.Yoo S, Mittelstein DR, Hurt RC, Lacroix J & Shapiro MG Focused ultrasound excites cortical neurons via mechanosensitive calcium accumulation and ion channel amplification. Nature Communications 13, 493 (2022). [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 23.Murphy KR et al. Optimized ultrasound neuromodulation for non-invasive control of behavior and physiology. Neuron (2024). [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 24.Kubanek J, Shukla P, Das A, Baccus SA & Goodman MB Ultrasound Elicits Behavioral Responses through Mechanical Effects on Neurons and Ion Channels in a Simple Nervous System. J. Neurosci 38, 3081–3091 (2018). [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 25.Duck F Acoustic Dose and Acoustic Dose-Rate. Ultrasound in Medicine & Biology 35, 1679–1685 (2009). [DOI] [PubMed] [Google Scholar]

RESOURCES